Multiple myeloma results from the degeneration of a single plasma cell whose clones spread throughout the bone marrow. Overall, the disease occurs very rarely. However, it is one of the most common tumors of bone and bone marrow. Intensive research is being conducted into the non-Hodgkin’s lymphoma group in order to improve the prognosis of those affected in the long term.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Leoni Burggraf
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Chronic urticaria
“Treat-to-target” approach is underpinned by new findings
- Dual GIP/GLP-1 RA in type 2 diabetes
Tirzepatide proves multiple benefits
- Pain syndrome
From pathophysiology to therapy – a reminder
- Sunscreen
Increasing risk of skin cancer due to dangerous UV radiation
- Coronary heart disease and type 2 diabetes
Relationship between baseline FFA values and all-cause mortality.
- Esophagus
Therapy of esophageal carcinoma – an overview
- Visceral Surgery Update - Part 1
Upper gastrointestinal tract and robotic visceral surgery
- Case reports: Pityriasis rubra pilaris (PRP)